Major Ingredients

Each tablet contains Risperidone USP 2.0mg.

Major Functionality

Resco (Risperidone) is indicated for the treatment of Acute and chronic schizophrenic psychosis, and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness) and/or negative symptoms (such as blunted affect, emotional and social withdrawal, poverty of speech) are prominent. Risperidone also alleviates affective symptoms (such as depression, guilt feelings, anxiety) associated with schizophrenia. Also indicated at behavioral disturbances in patients with dementia where aggressive symptoms (verbal outbursts, physical violence), activity disturbances (agitation, wandering) or psychotic symptoms are prominent

Manufacture Information

Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.